Angela McLigeyo , 1 Jamilla Rajab,2 Mohammed Ezzi,2 Peter Oyiro,3 Yatich Bett,4 Andrew Odhiambo,2 Matilda Ong’ondi,3 Sitna Mwanzi , Mercy Gatua, and NAOthieno- Abinya (Hindawi, 2020)
Imatinib mesylate is the gold standard for the treatment of all phases of Philadelphia-positive chronic myeloid
leukemia. Patients on imatinib treatment may develop cytopenia due to drug toxicity. *is study aimed to ...